Veradermics MANE Ratios (2025-2026)

NYSE MANE
$117.54 +2.54 (+2.21%)
As of: Sep 29, 2026 · 3:59 PM EDT
Reported Financials

Veradermics Quarterly Ratios

Periods 5 quarters
Latest Jun 2026

Veradermics ratios data for the quarter ended Jun 2026. These financial ratios cover 5 quarters of results from Mar 2025 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2025 Jun2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 274.99M611.55M
Equity AverageEquity Avg. -54.57M-68.37M-98.54M134.81M602.13M
Valuation
Price to BookP/B 3.676.31
Enterprise Value 1,042.97M4,316.56M
Market Capitalization 1,433.77M5,136.45M
Return Ratios
Return on Capital Employed [ROCE]ROCE -14.74%
Return on Assets [ROA]ROA -12.88%
Return on Equity [ROE]ROE -13.08%

Veradermics Ratios API

Pull Veradermics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MANE&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY